The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic disease
Abstract
Background: Hepatic surgery is presumed to improve survival of patients with liver metastases (LM) from neuroendocrine tumours (NET). This study identified LM-specific variables that could be used as additional selection criteria for aggressive treatment. Methods: A novel classification of LM from NET was established based on their localization and presentation. Results: From 1992 to 2006, 119 patients underwent staging and treatment of LM. Three growth types of LM were identified radiologically: single metastasis (type I), isolated metastatic bulk accompanied by smaller deposits (type II) and disseminated metastatic spread (type III). The three groups differed significantly in terms of chronological presentation of LM, hormonal symptoms, Ki-67 index, 5-hydroxyindoleacetic acid and chromogranin A levels, lymph node involvement, presence of bone metastases and treatment options. The 3-, 5- and 10-year disease-specific survival rates for the entire cohort were 76·4, 63·9 and 46·5 per cent respectively. There were significant differences in survival between the three groups: 5- and 10-year rates were both 100 per cent for type I, 84 and 75 per cent respectively for type II, and 51 and 29 per cent for type III. Conclusion: The localization and biological features of LM from NET defines therapeutic management and is predictive of outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A 5‐decade analysis of 13,715 carcinoid tumors
Modlin, I. M., Lye, K. D., & Kidd, M. (2003) · Cancer · doi:10.1002/cncr.11105 · Cited by 2,734
Krenning, E. P., Kwekkeboom, D. J., Bakker, W. H., Breeman, W. A. P., Kooij, P. P. M., Oei, H. Y., van Hagen, M., Postema, P. T. E., de Jong, M., Reubi, J. C., et al. (1993) · European Journal of Nuclear Medicine · doi:10.1007/bf00181765 · Cited by 1,564
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system
Rindi, G., Klöppel, G., Alhman, H., Caplin, M., Couvelard, A., de Herder, W. W., Erikssson, B., Falchetti, A., Falconi, M., Komminoth, P., et al. (2006) · Virchows Archiv · doi:10.1007/s00428-006-0250-1 · Cited by 1,547
Histological Typing of Lung and Pleural Tumours
Travis, W. D., Colby, T. V., Corrin, B., Shimosato, Y., & Brambilla, E. (1999) · Springer eBooks · doi:10.1007/978-3-642-60049-4 · Cited by 1,523
Carcinoid TumorsAn analysis of 2837 cases
Godwin, J. D. (1975) · Cancer · doi:10.1002/1097-0142(197508)36:2<560::aid-cncr2820360235>3.0.co;2-4 · Cited by 1,106
Gabriel, M., Decristoforo, C., Kendler, D., Dobrozemsky, G., Heute, D., Uprimny, C., Kovacs, P., Von Guggenberg, E., Bale, R., & Virgolini, I. J. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.035667 · Cited by 1,010
Ramage, J. K., Ahmed, A., Ardill, J., Bax, N., Breen, D. J., Caplin, M. E., Corrie, P., Davar, J., Davies, A. H., Lewington, V, et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300831 · Cited by 952
Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system
Strasberg, S. M. (2005) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s00534-005-0999-7 · Cited by 901
Sarmiento, J. M., Heywood, G., Rubin, J., Ilstrup, D. M., Nagorney, D. M., & Que, F. G. (2003) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(03)00230-8 · Cited by 773
Histological Typing of Endocrine Tumours
Solcia, E., Klöppel, G., & Sobin, L. H. (2000) · Springer eBooks · doi:10.1007/978-3-642-59655-1 · Cited by 747
Hepatic neuroendocrine metastases: does intervention alter outcomes?1
Chamberlain, R. S., Canes, D., Brown, K. T., Saltz, L., Jarnagin, W., Fong, Y., & Blumgart, L. H. (2000) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(00)00222-2 · Cited by 622
Guidelines for the Diagnosis and Treatment of Neuroendocrine Gastrointestinal Tumours
Plöckinger, U., Rindi, G., Arnold, R., Eriksson, B., Krenning, E. P., de Herder, W. W., Goede, A., Caplin, M., Öberg, K., Reubi, J. C., et al. (2004) · Neuroendocrinology · doi:10.1159/000085237 · Cited by 477
Gupta, S., Johnson, M. M., Murthy, R., Ahrar, K., Wallace, M. J., Madoff, D. C., McRae, S. E., Hicks, M. E., Rao, S., Vauthey, J., et al. (2005) · Cancer · doi:10.1002/cncr.21389 · Cited by 433
Cytoreductive hepatic surgery for neuroendocrine tumors.
Gp, M., Nagorney, D. M., Lk, K., Cg, M., & Cs, G. (1990) · PubMed · Cited by 381
Isolated Liver Metastases from Neuroendocrine Tumors: Does Resection Prolong Survival?
Chen, H., Hardacre, J. M., Uzar, A., Cameron, J. L., & Choti, M. A. (1998) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(98)00099-4 · Cited by 371
Neuroendocrine Hepatic Metastases: Does Aggressive Management Improve Survival?
Touzios, J. G., Kiely, J. M., Pitt, S. C., Rilling, W. S., Quebbeman, E. J., Wilson, S. D., & Pitt, H. A. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000161981.58631.ab · Cited by 362
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours
Ramage, J. K., Davies, A. H. G., Ardill, J., Bax, N., Caplin, M., Grossman, A., Hawkins, R., McNicol, A. M., Reed, N., Sutton, R., et al. (2005) · Gut · doi:10.1136/gut.2004.053314 · Cited by 350
Mazzaglia, P. J., Berber, E., Milas, M., & Siperstein, A. E. (2007) · Surgery · doi:10.1016/j.surg.2007.01.036 · Cited by 256
Aggressive surgery for metastatic liver neuroendocrine tumors
Norton, J. A., Warren, R. S., Kelly, M. G., Zuraek, M. B., & Jensen, R. T. (2003) · Surgery · doi:10.1016/j.surg.2003.07.025 · Cited by 255
Islet cell carcinomas of the pancreas: a twenty-year experience.
Thompson, G. B., van Heerden, J. A., Grant, C. S., Carney, J. A., & Ilstrup, D. M. (1988) · PubMed · Cited by 249
Elias, D., Lasser, P., Ducreux, M., Duvillard, P., Ouellet, J.-F., Dromain, C., Schlumberger, M., Pocard, M., Boige, V., Miquel, C., et al. (2003) · Surgery · doi:10.1067/msy.2003.114 · Cited by 237
Hepatic surgery for metastases from neuroendocrine tumors
Sarmiento, J. M., & Que, F. G. (2003) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(02)00076-5 · Cited by 227
Osborne, D. A., Zervos, E. E., Strosberg, J., Boe, B. A., Malafa, M., Rosemurgy, A. S., Yeatman, T. J., Carey, L., Duhaine, L., & Kvols, L. K. (2006) · Annals of Surgical Oncology · doi:10.1245/aso.2006.03.071 · Cited by 220
Ho, A. S., Picus, J., Darcy, M. D., Tan, B., Gould, J. E., Pilgram, T. K., & Brown, D. B. (2007) · American Journal of Roentgenology · doi:10.2214/ajr.06.0933 · Cited by 158
Orthotopic Liver or Multivisceral Transplantation As Treatment of Metastatic Neuroendocrine Tumors
Olausson, M., Friman, S., Herlenius, G., Cahlin, C., Nilsson, O., Jansson, S., Wängberg, B., & Ahlman, H. (2007) · Liver Transplantation · doi:10.1002/lt.21056 · Cited by 158
van Vilsteren, F. G. I., Baskin-Bey, E. S., Nagorney, D. M., Sanderson, S. O., Kremers, W. K., Rosen, C. B. B., Gores, G. J., & Hobday, T. J. (2006) · Liver Transplantation · doi:10.1002/lt.20702 · Cited by 147
Update on the Management of Neuroendocrine Hepatic Metastases
Madoff, D. C., Gupta, S. K., Ahrar, K., Murthy, R., & Yao, J. C. (2006) · Journal of Vascular and Interventional Radiology · doi:10.1097/01.rvi.0000232177.57950.71 · Cited by 129
Öberg, K. (2004) · Acta Oncologica · doi:10.1080/02841860410018502 · Cited by 120
Members of Nordic Ne Tumour Group:, Öberg, K., Astrup, L. B., Eriksson, B. K., Falkmer, S. E., Falkmer, S., Gustafsen, J., Haglund, C., Knigge, U., Vatn, M. H., et al. (2004) · Acta Oncologica · doi:10.1080/02841860410018575 · Cited by 105
Schillaci, O., Spanu, A., Scopinaro, F., Falchi, A., Danieli, R., Marongiu, P., Pisu, N., Madeddu, G., Fave, G. D., & Madeddu, G. (2003) · PubMed · Cited by 102
Treatment with 90Y- and 177Lu-DOTATOC in patients with metastatic neuroendocrine tumors
Frilling, A., Weber, F., Saner, F. H., Bockisch, A., Hofmann, M., Mueller‐Brand, J., & Broelsch, C. E. (2006) · Surgery · doi:10.1016/j.surg.2006.07.030 · Cited by 90
Self-citationHighly aggressive policy of hepatic resections for neuroendocrine liver metastases.
Grazi, G. L., Cescon, M., Pierangeli, F., Ercolani, G., Gardini, A., Cavallari, A., & Mazziotti, A. (2000) · PubMed · Cited by 75
Elias, D. M., Sidéris, L., Liberale, G., Ducreux, M. P., Malka, D., Lasser, P., Duvillard, P., & Baudin, É. (2005) · Surgery · doi:10.1016/j.surg.2004.11.007 · Cited by 69
Cited by
Ramage, J. K., Ahmed, A., Ardill, J., Bax, N., Breen, D. J., Caplin, M. E., Corrie, P., Davar, J., Davies, A. H., Lewington, V, et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300831 · Cited by 952
Recommendations for management of patients with neuroendocrine liver metastases
Frilling, A., Modlin, I. M., Kidd, M., Russell, C., Breitenstein, S., Salem, R., Kwekkeboom, D., Lau, W.-Y., Klersy, C., Vilgrain, V., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70362-0 · Cited by 527
Self-citationBinderup, T., Knigge, U., Loft, A., Federspiel, B., & Kjaer, A. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1759 · Cited by 489
Le Treut, Y. P., Grégoire, E., Klempnauer, J., Belghiti, J., Jouve, E., Lerut, J., Castaing, D., Soubrane, O., Boillot, O., Mantion, G., et al. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e31828ee17c · Cited by 260
Treatment of Liver Metastases in Patients with Neuroendocrine Tumors: A Comprehensive Review
Harring, T. R., Nguyen, N. T. N., Goss, J. A., & O'Mahony, C. A. (2011) · International Journal of Hepatology · doi:10.4061/2011/154541 · Cited by 69
Metadata
- Authors
- Frilling, A., Li, J., Malamutmann, E., Schmid, K.-W., Bockisch, A., & Broelsch, C. E.
- Venue
- British Journal of Surgery
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-01-21
- Volume
- 96
- Issue
- 2
- Pages
- 175-184
- ISSN
- 0007-1323 (ISSN-L)
- 1365-2168
- OpenAlex
- W1975031233
- Cited by
- 257
- References
- 33
- FWCI
- 8.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.